{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Paliperidone&page=3", "query": { "intervention": "Paliperidone", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 59, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Paliperidone&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Paliperidone&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-17T07:32:22.708Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02600741", "title": "Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Caregiver psycho-education and skills training", "type": "OTHER" }, { "name": "Caregiver support available at the study site", "type": "OTHER" }, { "name": "Paliperidone palmitate", "type": "DRUG" }, { "name": "Chlorpromazine", "type": "DRUG" }, { "name": "Droperidol", "type": "DRUG" }, { "name": "Fluphenazine", "type": "DRUG" }, { "name": "Haloperidol", "type": "DRUG" }, { "name": "Loxapine", "type": "DRUG" }, { "name": "Perphenazine", "type": "DRUG" }, { "name": "Pimozide", "type": "DRUG" }, { "name": "Prochlorperazine", "type": "DRUG" }, { "name": "Thiothixene", "type": "DRUG" }, { "name": "Thioridazine", "type": "DRUG" }, { "name": "Trifluoperazine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Asenapine", "type": "DRUG" }, { "name": "Clozapine", "type": "DRUG" }, { "name": "Iloperidone", "type": "DRUG" }, { "name": "Olanzapine", "type": "DRUG" }, { "name": "Paliperidone", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" }, { "name": "Ziprasidone", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 296, "start_date": "2015-07-24", "completion_date": "2018-07-05", "has_results": false, "last_update_posted_date": "2019-01-23", "last_synced_at": "2026-10-17T07:32:22.708Z", "location_count": 34, "location_summary": "Bullhead City, Arizona • Oceanside, California • Denver, Colorado + 31 more", "locations": [ { "city": "Bullhead City", "state": "Arizona" }, { "city": "Oceanside", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Lauderdale Lakes", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02600741" }, { "nct_id": "NCT01150448", "title": "A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Paliperidone palmitate Treatment A", "type": "DRUG" }, { "name": "Paliperidone palmitate Treatment B", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 212, "start_date": "2007-09", "completion_date": "2009-06", "has_results": false, "last_update_posted_date": "2014-05-28", "last_synced_at": "2026-10-17T07:32:22.708Z", "location_count": 5, "location_summary": "Cerritos, California • National City, California • San Diego, California + 2 more", "locations": [ { "city": "Cerritos", "state": "California" }, { "city": "National City", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01150448" }, { "nct_id": "NCT01193153", "title": "A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizoaffective Disorder" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "paliperidone palmitate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 667, "start_date": "2010-09", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2015-01-05", "last_synced_at": "2026-10-17T07:32:22.708Z", "location_count": 28, "location_summary": "Garden Grove, California • Oakland, California • Oceanside, California + 25 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Pico Rivera", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01193153" }, { "nct_id": "NCT01136772", "title": "A Comparison of Long-acting Injectable Medications for Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "haloperidol decanoate", "type": "DRUG" }, { "name": "paliperidone palmitate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 311, "start_date": "2011-03", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2016-10-21", "last_synced_at": "2026-10-17T07:32:22.708Z", "location_count": 22, "location_summary": "Palo Alto, California • New Haven, Connecticut • Miami, Florida + 19 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01136772" }, { "nct_id": "NCT01556763", "title": "Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder", "Central Nervous System Diseases" ], "interventions": [ { "name": "EVP-6124 (0.3 mg/day)", "type": "DRUG" }, { "name": "EVP-6124 (1.0 mg/day)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Antipsychotic therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "FORUM Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 21, "start_date": "2008-04", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2012-06-21", "last_synced_at": "2026-10-17T07:32:22.708Z", "location_count": 1, "location_summary": "Wichita, Kansas", "locations": [ { "city": "Wichita", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01556763" }, { "nct_id": "NCT02472652", "title": "Aripiprazole, Abilify Maintena Collaborative Clinical Protocol", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sexual Dysfunction" ], "interventions": [ { "name": "Abilify Maintena", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gazda, Thomas D., M.D., PC", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 2, "start_date": "2015-06", "completion_date": "2017-03-01", "has_results": true, "last_update_posted_date": "2019-04-11", "last_synced_at": "2026-10-17T07:32:22.708Z", "location_count": 1, "location_summary": "Bullhead City, Arizona", "locations": [ { "city": "Bullhead City", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02472652" }, { "nct_id": "NCT00946985", "title": "28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "paliperidone palmitate", "type": "DRUG" }, { "name": "oral risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ortho-McNeil Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "18 Years to 35 Years" }, "enrollment_count": 163, "start_date": "2009-06", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2012-09-10", "last_synced_at": "2026-10-17T07:32:22.708Z", "location_count": 23, "location_summary": "Little Rock, Arkansas • Garden Grove, California • San Diego, California + 20 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Garden Grove", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Kissimmee", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00946985" }, { "nct_id": "NCT01786369", "title": "Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Schizophrenia", "Schizoaffective Disorder", "Bipolar Disorder" ], "interventions": [], "intervention_types": [], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 106, "start_date": "2013-02", "completion_date": "2015-04", "has_results": false, "last_update_posted_date": "2015-04-14", "last_synced_at": "2026-10-17T07:32:22.708Z", "location_count": 1, "location_summary": "Glen Oaks, New York", "locations": [ { "city": "Glen Oaks", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01786369" }, { "nct_id": "NCT04002700", "title": "A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stroke" ], "interventions": [ { "name": "Haloperidol", "type": "DRUG" }, { "name": "Typical Antipsychotics", "type": "DRUG" }, { "name": "Atypical Antipsychotics", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1234412, "start_date": "2019-05-06", "completion_date": "2019-05-31", "has_results": false, "last_update_posted_date": "2025-06-25", "last_synced_at": "2026-10-17T07:32:22.708Z", "location_count": 1, "location_summary": "Titusville, New Jersey", "locations": [ { "city": "Titusville", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04002700" }, { "nct_id": "NCT05741502", "title": "An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Treatment-resistant Schizophrenia" ], "interventions": [ { "name": "Clozapine", "type": "DRUG" }, { "name": "Antipsychotics,Other (non-Clozapine)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 5, "start_date": "2023-08-16", "completion_date": "2026-01-23", "has_results": false, "last_update_posted_date": "2026-02-25", "last_synced_at": "2026-10-17T07:32:22.708Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05741502" } ] }